Atropine in the Treatment of Myopia Study in Malaysia

Exclusion Criteria

• •1. History of hypersensitivity or allergy to study drug and/or any of the study medication ingredients.
• •2. Children with prior and/or concomitant use of other myopia control drugs, contact lens or spectacles (except normal spectacles including tinted/anti-glare glasses) etc.
• •3. Children with congenital myopia.
• •4. Children using Ortho K and Myopia Lens.
• •5. Children with ocular or systemic diseases which may affect vision or refractive error.
• •6. Children with any ocular condition wherein topical atropine is contraindicated.
• •7. Children with defective binocular function or stereopsis.
• •8. Children with amblyopia (lazy eyes) or manifest strabismus including intermittent tropia.
• •9. Previous or current use of atropine or pirenzepine.
• •10. Children with any other conditions precluding adherence to the protocol including unwillingness to refrain from the use of other myopia control drug, contact lens or spectacles (except normal) spectacles including tinted/anti-glare glasses) etc. for the duration of the study.
• •11. Children with any other condition which may put the subject to risk during study or affect study results based on investigator's judgement.
• •12. Children participated in any clinical study within 30 days prior to randomization.